Molecular characterization of circulating tumor cells in ovarian cancer

American Journal of Cancer Research

Volumn 6, Issue 5, 2016, Pages 973-980

  Kolostova, Katarina ^a   Pinkas, Michael ^a   Jakabova, Anna ^a   Pospisilova, Eliska ^a   Svobodova, Pavla ^a   Spicka, Jan ^a   Cegan, Martin ^b   Matkowski, Rafal ^c,d   Bobek, Vladimir ^a,b,c,e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Masaryk s Hospital in Usti nad Labem   (Czech Republic)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d Wroclaw   (Poland)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Circulating tumor cells; CTCs; Cultivation; Gene expression; In vitro; MetaCell; Ovarian cancer

Indexed keywords

CD68 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MUCIN; MUCIN 1; MUCIN 16; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; RNA RECOGNITION MOTIF 1 PROTEIN; RNA RECOGNITION MOTIF 2 PROTEIN; RNA RECOGNITION MOTIF PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; WT1 PROTEIN;

ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER PATIENT; CELL SIZE; CELL STRUCTURE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENRICHMENT CULTURE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 85006210840     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Josse SA, Pantel K. Biologic challenges in the detection of circulating tumor cells. Cancer Res 2013; 73: 8-11.
2. Ning Y, Gerger A, Zhang W, Hanna DL, Yang D, Winder T, Wakatsuki T, Labonte MJ, Stintzing S, Volz N, Sunakawa Y, Stremitzer S, El-Khoueiry R, Lenz HJ. Plastin polymorphisms predict genderand stage-specific colon cancer recurrence after adjuvant chemotherapy. Mol Cancer Ther 2014; 13: 528-39.
3. Kolostova K, Matkowski R, Jedryka M, Soter K, Cegan M, Pinkas M, Jakabova A, Pavlasek J, Spicka J, Bobek V The added value of circulating tumor cells examination in ovarian cancer staging. Am J Cancer Res 2015; 5: 3363-75
4. Kolostova K, Spicka J, Matkowski R, Bobek V. Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers. Am J Transl Res 2015; 7: 1203-13.
5. Herlyn M, Steplewski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A 1979; 76: 1438-42.
6. Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 2012; 12: 178.
7. Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, Lackner MR. Molecular biomarker analyses using circulating tumor cells. PLoS One 2010; 5: e12517.
8. Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol 2011; 50: 700-10.
9. Alix-Panabières C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer 2014; 14: 623-31.
10. Driemel C, Kremling H, Schumacher S, Will D, Wolters J, Lindenlauf N, Mack B, Baldus SA, Hoya V, Pietsch JM, Panagiotidou P, Raba K4, Vay C, Vallböhmer D, Harréus U, Knoefel WT, Stoecklein NH, Gires O. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer. Oncogene 2014; 33: 4904-15.